INCREASED SYNTHESIS OF EXTRACELLULAR-MATRIX IN MESANGIAL PROLIFERATIVE NEPHRITIS

被引:283
作者
FLOEGE, J [1 ]
JOHNSON, RJ [1 ]
GORDON, K [1 ]
IIDA, H [1 ]
PRITZL, P [1 ]
YOSHIMURA, A [1 ]
CAMPBELL, C [1 ]
ALPERS, CE [1 ]
COUSER, WG [1 ]
机构
[1] UNIV WASHINGTON,MED CTR,DEPT PATHOL,SEATTLE,WA 98195
关键词
D O I
10.1038/ki.1991.235
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Extracellular matrix expansion is frequently noted in mesangioproliferative renal diseases. This study investigates the role of immunologic factors in glomerular matrix accumulation. The gene expression of type I and IV collagen, laminin and s-laminin was examined in the rat model of mesangial proliferative glomerulonephritis induced with anti-Thy 1.1 antibody. Northern analysis was performed on glomerular RNA isolated one, three and five days after disease induction and at day 3 following prior complement depletion. Tissue was immunostained for the protein products of these genes as well as for heparan sulfate proteoglycan, entactin and PCNA (a marker of cell proliferation) at days 1, 3, 5, 14, 21 and 42. A seven- to ten-fold increase of collagen IV and laminin mRNA as well as de novo expression of collagen I mRNA occurred at days 3 and 5 corresponding to the time of maximal proliferation. S-laminin mRNA levels only increased three-fold. With the exception of s-laminin, mesangial staining for all examined matrix proteins increased to a maximum at day 5 and decreased thereafter. Focal alterations of the glomerular architecture and matrix persisted al day 42. Complement depletion prevented the histological abnormalities as well as the increased expression of matrix proteins at day 3. These findings indicate that immunologic injury in the mesangium may result in overproduction of extracellular matrix components and may ultimately contribute to the development of glomerulosclerosis.
引用
收藏
页码:477 / 488
页数:12
相关论文
共 63 条
[1]
PHENOTYPIC-EXPRESSION OF COLLAGEN TYPES IN MESANGIAL MATRIX OF DIABETIC AND NONDIABETIC RATS [J].
ABRASS, CK ;
PETERSON, CV ;
RAUGI, GJ .
DIABETES, 1988, 37 (12) :1695-1702
[2]
ADLER S, 1986, AM J PATHOL, V123, P553
[3]
BAGCHUS WM, 1990, AM J PATHOL, V137, P215
[4]
BAGCHUS WM, 1986, LAB INVEST, V55, P680
[5]
BENDER BL, 1981, AM J PATHOL, V103, P419
[6]
TRANSFORMING GROWTH FACTOR-B REGULATES PRODUCTION OF PROTEOGLYCANS BY MESANGIAL CELLS [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
RUOSLAHTI, E .
KIDNEY INTERNATIONAL, 1990, 37 (02) :689-695
[7]
SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[8]
CARLIN B, 1981, J BIOL CHEM, V256, P5209
[9]
CASTELLOT JJ, 1985, AM J PATHOL, V120, P427
[10]
CHAKRAVARTI S, 1990, J BIOL CHEM, V265, P10597